Abstract:Aims To explore healthcare professionals' perceptions and experiences of take‐home naloxone initiatives in acute care settings to gain an understanding of issues facilitating or impeding dispensing. Design Systematic literature review. Data Sources Cochrane, MEDLINE and CINAHL were searched from 15/03/2021 to 18/03/2021, with a follow‐up search performed via PubMed on 22/03/2021. The years 2011 to 2021 were included in the search. Review Methods A systematic literature review focused on qualitative studies and quantitative survey designs. Synthesis without meta‐analysis was undertaken using a thematic analysis approach. Results Seven articles from the United States of America (5), Australia (1) and Canada (1) with 750 participants were included in the review. Results indicate ongoing stigma towards people who use drugs with preconceived moral concerns regarding take‐home naloxone. There was confusion regarding roles and responsibilities in take‐home naloxone dispensing and patient education. Similarly, there was a lack of clarity over logistical and financial issues. Conclusion Take‐home naloxone is a vital harm reduction initiative. However, barriers exist that prevent the optimum implementation of these initiatives. Impact What is already known: Deaths due to opioid overdose are a global health concern, with take‐home naloxone emerging as a key harm reduction scheme. Globally, less than 10% of people who use drugs have access to treatment initiatives, including take‐home naloxone. An optimum point of distribution of take‐home naloxone is post‐acute hospital care. What this paper adds: There is role confusion regarding responsibility for the provision of take‐home naloxone and patient education. This is exacerbated by inconsistent provision of training and education for healthcare professionals. Logistical or financial concerns are common and moral issues are prevalent with some healthcare professionals questioning the ethics of providing take‐home naloxone. Stigma towards people who use drugs remains evident in some acute care areas which may impact the use of this intervention. Implications for practice/policy: Further primary research should examine what training and education methods are effective in improving the distribution of take‐home naloxone in acute care. Education should focus on reduction of stigma towards people who use drugs to improve the distribution of take‐home naloxone. Standardized care guidelines may ensure interventions are offered equally and take‐home naloxone 'champions' could drive initiatives forward, with support from harm reduction specialists. Reporting Method This has adhered to the PRISMA reporting guidelines for systematic reviews. Patient or Public Contribution No patient or public contribution.

Interventions to increase naloxone access for undergraduate students: A systematic review of the literature

Lowering barriers to naloxone access through a student-led harm reduction program

Naloxone administration for suspected opioid overdose: An expanded scope of practice by a basic life support collegiate-based emergency medical services agency

"SafetyNet": Evaluation of a Recovery Coach and Paramedic Intervention Following Naloxone Resuscitation From an Opioid Overdose

Effectiveness of direct patient outreach with a narrative naloxone and overdose prevention video to patients prescribed long-term opioid therapy in the USA: the Naloxone Navigator randomised clinical trial

Pharmacists' perceptions regarding feasibility, acceptability, and usefulness of student-delivered naloxone education services in community pharmacy: A mixed methods study in Alabama

Implementing a text-message-based intervention to increase access to naloxone for patients on chronic opioid therapy

A mixed methods study to inform fatal overdose prevention in San Diego, California: Perspectives from people who use drugs

Opioid overdose counseling and prescribing of naloxone in rural community pharmacies: A pilot study

Application of The Consolidated Framework for Implementation Research to inform understanding of barriers and facilitators to the implementation of opioid and naloxone training on college campuses

Implementation of an EMS-based naloxone distribution program: A qualitative evaluation

Effect of the Communities That HEAL Intervention on Overdose Education and Naloxone Distribution: A Cluster-Randomized, Wait-List Controlled Trial

State program enables the identification of factors associated with naloxone awareness, self-efficacy, and use for overdose reversal: A cross-sectional, observational study in an urban emergency department population

Reducing the Likelihood of Opioid Overdose Fatalities on College and University Campuses: An Action Plan and Model

A systematic review exploring healthcare professionals' perceptions of take‐home naloxone dispensing in acute care areas

Naloxone Dispensing to Youth Ages 10-19: 2017-2022

Naloxone-Prescribing Practices in a Freestanding Rehabilitation Hospital

Co-prescription of naloxone as a Universal Precautions model for patients on chronic opioid therapy—Observational study

A Practical Guide to Implementing an Evidenced-Based Hands-On Naloxone Training

Substance Use and Overdose in Pennsylvania Libraries, 2019

Trends and Characteristics during 17 Years of Naloxone Distribution and Administration through a Harm Reduction Program in Pittsburgh, Pennsylvania